14:33:09 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-21 Bokslutskommuniké 2024
2024-11-21 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-06-25 Ordinarie utdelning CODE 0.00 NOK
2024-06-24 Årsstämma 2024
2024-05-07 Kvartalsrapport 2024-Q1
2024-02-23 Bokslutskommuniké 2023
2023-11-30 Extra Bolagsstämma 2023
2023-08-30 Kvartalsrapport 2023-Q2
2023-06-23 Årsstämma 2023
2023-05-25 Kvartalsrapport 2023-Q1
2023-05-02 Ordinarie utdelning CODE 2.50 NOK
2023-02-28 Bokslutskommuniké 2022
2022-11-11 Kvartalsrapport 2022-Q3
2022-08-29 Kvartalsrapport 2022-Q2
2022-06-28 Årsstämma 2022
2022-06-03 Ordinarie utdelning CODE 0.00 NOK
2022-05-20 Kvartalsrapport 2022-Q1
2021-10-13 Extra Bolagsstämma 2021
2021-06-11 Ordinarie utdelning CODE 0.00 NOK
2021-06-10 Årsstämma 2021

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
CodeLab Capital är ett norskt bolag verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av mjukvarulösningar. Programvaran är egenutvecklad och används huvudsakligen inom vård och omsorg för uppföljning och analys. Utöver huvudverksamheten erbjuds diverse mervärdestjänster. Störst verksamhet återfinns inom den nordiska marknaden.
2021-08-27 12:00:00
The Board of Directors of PatientSky Group AS (PSKY NO) has appointed Kristian
Ikast new CEO of the company. Ikast succeeds Johan Zetterström, effective from
today. The change underlines the board's ambitions for further and accelerated
international growth.

Kristian Ikast will step into the position from his current role as Board Member
at PatientSky with a deep working knowledge of the company, the people and the
strategy. Kristian will also bring a strong and dedicated business mindset, with
vast experience from large international corporations and the Danish army. He
knows the international market well and what it will take to succeed.

The Board of Directors would like to thank Johan Zetterström for his
contributions in listing the Company at Euronext Growth. We wish him all the
best going forward", says Chair of the Board, Jesper Melin.

"We have great ambitions for international growth for PatientSky. Our vision and
strategy have not changed. We have already changed our organizational set-up
into four focused business units. With the new CEO in place, we will scale up at
a faster pace, ensuring implementation and execution of our strategy. We are
heading in the same direction as before, but in a higher pace and with greater
quality for our customers and their patients," says Jesper Melin, founder and
Chair of PatientSky.